Sixth Element, PhoreMost spin out immuno-oncology newco

Sixth Element Capital LLC invested £3 million ($4 million) in newly created NeoPhore Ltd. (Cambridge, U.K.), a spinout from cancer company PhoreMost Ltd. (Cambridge, U.K.). The newco will seek to discover and develop small molecule immuno-oncology therapies to treat undisclosed cancer indications.

NeoPhore, the first asset-centric spinout of PhoreMost, will aim to build on discoveries already made by PhoreMost and its collaborators...